Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122715) titled 'Evaluation of the Effect and Analysis of Influencing Factors of Hepatitis B Vaccine Combined with Hepatitis B Immunoglobulin in Blocking Mother-to-Child Transmission of Hepatitis B in Jilin Province' on April 16.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Jilin Provincial Center for Disease Control and Prevention(Jilin Provincial Academy of Preventive Medicine)

Condition: Hepatitis B

Intervention: Single Immunotherapy Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-09-18

Target Sample Size: Single Immunotherapy Group:125;Co...